Tradestie Institutional Equity Comparison Engine

ABNG vs NDRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NDRA Overall Edge

NDRA Captures Institutional Edge (1โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ENDRA Life Sciences Inc. Common Stock (NDRA) driven by superior Growth & Margin while ABNG counters with relative strength in Momentum & Technical. Fundamentally, ABNG trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus NDRA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ABNG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NDRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ABNG N/M vs NDRA N/M Fwd P/E
Growth & Margin Winner NDRA
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner ABNG
1Y +45.3% vs -32.7% ยท 52W Pos 100% vs 37%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ABNG US Equity
ABNG
Institutional Equity
$20.21
+8.39% 1D
Market Cap N/A
1M Return +8.73%
1Y Return +45.31%
Forward P/E N/M
Unified AI Score
53.0 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 50.0 Mom 64.0
NDRA NASDAQ
ENDRA Life Sciences Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.42
+0.23% 1D
Market Cap $6.6M
1M Return -6.75%
1Y Return -32.72%
Forward P/E N/M
Unified AI Score
44.7 / 100 HOLD
Tech 35.0 Fund 46.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABNG +45.31% NDRA -32.72% Spread: +73.37 pp (ABNG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABNG TTM Op. Margin: N/A NDRA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABNG vs NDRA. Trailing 12-month operating profitability (ABNG N/A vs NDRA 0.0%) and valuation multiples (ABNG N/M vs NDRA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABNG (2) vs NDRA (6)
Institutional Metric ABNG NDRA Criterion Row Winner
Market Capitalization Scale N/A $6.6M Larger Scale NDRA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth NDRA
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin NDRA
Net Profit Margin Profitability N/A 0.0% Higher Margin NDRA
Return on Equity (ROE) Capital Efficiency N/A -152.0% Higher ROE NDRA
52-Week Range Position Momentum 100% ($13โ€“$20) 37% ($3โ€“$7) Stronger Trend ABNG
Beta / 30D Volatility Risk Regime 2.34ฮฒ ยท 71% Vol 0.71ฮฒ ยท 48% Vol Lower Realized Risk NDRA
Unified Institutional Score Composite Signal 53.0 / 100 (HOLD) 44.7 / 100 (HOLD) Higher Composite ABNG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABNG vs NDRA Buy Guide
ABNG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABNG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NDRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NDRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABNG nor NDRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.